DAFNA Capital Management LLC - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is and the CUSIP is 00771VAB4. A total of 24 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$1,476,000
+14.2%
1,500,0000.0%0.40%
+12.8%
Q2 2022$1,292,000
-3.9%
1,500,0000.0%0.35%
+0.6%
Q1 2022$1,345,000
+8.2%
1,500,0000.0%0.35%
+11.8%
Q4 2021$1,243,000
-9.6%
1,500,0000.0%0.31%
-14.2%
Q3 2021$1,375,000
-8.1%
1,500,0000.0%0.36%
+16.6%
Q2 2021$1,497,000
-3.8%
1,500,0000.0%0.31%
-15.2%
Q1 2021$1,556,000
+13.1%
1,500,0000.0%0.37%
-9.8%
Q4 2020$1,376,000
+14.1%
1,500,0000.0%0.41%
+4.3%
Q3 2020$1,206,0001,500,0000.39%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Birch Grove Capital LP 9,100,000$8,937,0003.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 174,372,000$170,826,0003.40%
PFM Health Sciences, LP 48,150,000$47,381,0001.71%
DeepCurrents Investment Group LLC 17,738,000$17,424,0000.67%
Weiss Asset Management LP 17,595,000$17,263,0000.42%
DAFNA Capital Management LLC 1,500,000$1,476,0000.40%
Westchester Capital Management, LLC 3,853,000$3,792,0000.11%
Calamos Advisors LLC 15,438,000$15,147,0000.07%
Verition Fund Management LLC 10,316,000$5,081,0760.06%
OAKTREE CAPITAL MANAGEMENT LP 2,532,000$2,491,0000.03%
View complete list of AERIE PHARMACEUTICALS INC shareholders